当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Abdurrahman Kedir Roble, Amin Ugas Mahad, Mekonin Meskelu Shegere, Endalkachew Mekonnen Eticha, Workineh Diriba Gemechu, Ahmed Mohamed Ibrahim, Girma Tadesse Wedajo, Ramadan Budul Yusuf
Background: Option B+ Prevention of Mother-To-Child HIV Transmission (PMTCT) is a global provider of antiretroviral therapy to pregnant and lactating women infected with HIV without eligibility criteria.
Objective: To determine the level of adherence and factors associated to Option B+ PMTCT among HIV-positive pregnant and lactating women.
Methodology: A cross-sectional study was carried out among 233 HIV-infected pregnant and lactating women who had been enrolled in PMTCT follow-up units in Jigjiga Hospitals. The sample size was calculated using a single-population proportion formula. Descriptive statistics were used to summarize the frequency and percentages of participants’ socio-demographic and clinical characteristics. Multivariate logistic regression was used to estimate factors associated with adherence to option B+ PMTCT drugs.
Results: The overall level of adherence to option B+ during pregnancy and breastfeeding was 73.4%. Pregnant and lactating women who had partner support [Adjusted Odd Ration (AOR) = 7.36, 95% CI (2.89, 18.71)] and initiated PMTCT service at the time of diagnosis [AOR = 2.75, 95% CI (1.01, 7.46)] were more likely adhered to the service than their comparators. Similarly, achieving higher educational level [AOR = 10.50, 95% CI (1.82, 60.76)] and five or more frequent antenatal care follow-ups [AOR = 5.71, 95% CI (1.15, 28.45)] were positively associated with good adherence.
Conclusion: In this study, the level of adherence to option B+ PMTCT service was less than the recommended adherence level to prevent vertical transmission.